Summary
Blood samples were taken from both antecubital veins in ten healthy volunteers. One side was anaesthetized beforehand with EMLA® cream covered with an occlusive dressing for 1 h and the other side served as a control. 19 routine clinical chemistry and haematology measurements were made. There were no clinically relevant alterations in any of the measurements. It is concluded that EMLA cream can be used to anaesthetize normal skin before blood sampling without any risk of distorting the results of the analyses of the blood.
References
Ehrenström Reiz GME, Reiz SLA (1982) EMLA—a eutectic mixture of local anaesthetics for topical anaesthesia. Acta Anaesth Scand 26: 596–598
Juhlin L, Evers H, Broberg F (1980) A lidocaine-prilocaine cream for superficial skin surgery and painful lesions. Acta Derm Venereol (Stockh) 60: 544–546
Hallén B, Carlsson P, Uppfeldt A (1985) Clinical study of a lignocaine-prilocaine cream to relieve the pain of venepuncture. Br J Anaesth 57: 326–328
Dohlwitz A, Uppfeldt A (1985) Schmerzlinderung bei Venenpunktion. Applikationszeit und Wirksamkeit einer Lidocain-Prilocain-Creme. Anaesthesist 34: 355–358
Cooper CM, Gerrish SP, Hardwick M, Kay R (1987) EMLA cream reduces the pain of venepuncture in children. Eur J Anaesthesiol 4: 441–448
Clarke S, Radford M (1986) Topical anaesthesia for venepuncture. Arch Dis Child 61: 1132–1134
Juhlin L, Hägglund G, Evers H (1989) Absorption of lidocaine and prilocaine after application of a eutectic mixture of local anesthetics (EMLA®) on normal and diseased skin. Acta Derm Venereol (Stockh) 69: 18–22
Pocock SJ, Geller NL, Tsiatis AA (1987) The analysis of multiple endpoints in clinical trials. Biometrics 43: 487–498
Friedman LM, Furberg CD, DeMets DL (1985) Fundamentals of clinical trials. Second edition. PSG, Littleton, Massachusetts, p 256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amdisen, A., Glud, V. & Petersen, K.P. No influence from topical application of EMLA® cream before blood sampling on routine clinical chemistry and haematology measurements. Eur J Clin Pharmacol 41, 619–620 (1991). https://doi.org/10.1007/BF00314997
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314997